Stanford Cancer Institute Directory

Lymphoma & Leukemia Profiles

Showing 1 - 10 of 23
    Saul A. Rosenberg, MD, Professor of Lymphoma


    Ranjana H. Advani, MD is the Saul Rosenberg Professor of Lymphoma and serves as the Physician Leader of the Lymphoma Clinical Care Program. She specializes in research and treatment of Hodgkin and non-Hodgkin lymphomas and has developed a broad collaborative investigative program, encompassing clinical trials and translational correlates. She is the Principle Investigator on numerous clinical trials. She currently serves on the National Comprehensive Cancer Network (NCCN) non Hodgkin and Hodgkin Lymphoma (vice chair) guidelines panel, Lymphoma Core Committee of the Eastern Cooperative Oncology Group (ECOG) and is the co-chair of the National Cancer Institute Lymphoma Steering Committee.
    Assistant Professor of Medicine (Oncology)
    Assistant Professor (Research) of Pathology
    Professor of Medicine (Hematology) at the Stanford University Medical Center
    Assistant Professor of Chemical and Systems Biology
    Professor of Medicine (Oncology) and of Pathology
    Professor of Medicine (Hematology) at the Stanford University Medical Center
    Henry S. Kaplan-Harry Lebeson Professor of Cancer Biology
    Professor of Structural Biology
    The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology) at the Stanford University Medical Center


    Youn H. Kim, M.D., is a Professor of Dermatology and member of the Stanford Cancer Institute. She is the Director of Stanford's Multidisciplinary Cutaneous Lymphoma Clinic/Program (MCLP). Her current research is dedicated towards strengthening the collaborative interface for novel discoveries and exploring new and improved therapies with tumor-specific targets and enhanced synergy and/or potency. She and her multidisciplinary colleagues are exploring novel immune/cell therapy modalities including in situ vaccination, immune checkpoint blockades, and unique allogeneic HSCT strategies.